Efficacy of Information System Regarding the Consumption of Antibiotics and Bacterial Resistance in Primary Care

• Conditions: Chronic Disease
• Interventions: Behavioral: Training program

• Registration Number: NCT02816528
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

France is a country strong consumer of antibiotics in Europe, specially in primary care.

Outpatient antibiotic use represents around 90% of total antibiotic use and prescriptions come mainly from general practitioners. A literature review of antibiotic stewardship in primary care show that there is no evaluation of interest of giving information about consumption of antibiotics and bacterial resistance to general practitioners. The objective of this study is to demonstrate that practitioners implicated in the followed of consumption of antibiotics and bacterial resistance around their geographical area of practice could change and improve their practices in good use of antibiotics.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-06-10
• Study Start: 2016-06-24
• Study First Submitted QC: 2016-06-24
• Study First Posted: 2016-06-28
• Status Verified: 2019-05
• Last Update Submitted: 2019-05-03
• Last Update Posted: 2019-05-06
• Primary Completion: 2020-06
• Study Completion: 2020-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 472

Inclusion Criteria

• General practitioners in a "Meurthe-et-Moselle" french department

Exclusion Criteria

• General practitioners out of "Meurthe-et-Moselle" french department

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Training program	Training program	Physicians will be given informations regarding antibiotic consumptions and bacterial resistance in their activity area every 3 months during 12 months.

Primary Outcome Measures

Name	Time	Method
Consumption of antibiotics	36 months	Antibiotics consumptions are provided by CNAMTS and calculated in defined daily dose DDD/1000 patient-days around the geographical area concerned by this study.

Secondary Outcome Measures

Name	Time	Method
Bacterial resistance of Escherichia coli and Staphylococcus aureus	36 months	The number of intermediate and resistant strains of E.coli and S.aureus are provided by MedQual around the geographical area concerned by this study.